<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100279'>Ulcerative colitis</z:hpo> (UC) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> condition requiring lifelong medication to minimize the incidence of symptomatic flares </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless, studies have shown that a large proportion of patients are nonadherent to their prescribed therapeutic regimen </plain></SENT>
<SENT sid="2" pm="."><plain>This review examines studies of patient adherence to <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> (<z:chebi fb="0" ids="6775">5-ASA</z:chebi>) therapy in real world settings and considers the reasons that patients do not adhere to medication </plain></SENT>
<SENT sid="3" pm="."><plain>Patients offer numerous reasons for not taking medication as prescribed; however, neither clinical nor community studies have consistently identified the same groups of patients as being high risk for poor adherence </plain></SENT>
<SENT sid="4" pm="."><plain>Indeed, the problem of nonadherence is complex and requires a combination of strategies to be improved </plain></SENT>
<SENT sid="5" pm="."><plain>Physicians, physician assistants, and nurse practitioners need to take the time to explain the importance of continual therapy, even when patients feel well, and should engage patients in a discussion to aid in the understanding of their nonadherence </plain></SENT>
<SENT sid="6" pm="."><plain>Then, healthcare providers can determine how to best amend the regimen to improve adherence </plain></SENT>
<SENT sid="7" pm="."><plain>As taking several tablets several times daily may be confusing or difficult for patients, higher strength <z:chebi fb="0" ids="6775">5-ASA</z:chebi> formulations that require fewer daily doses have the potential to enhance patient adherence as part of an overall management strategy </plain></SENT>
</text></document>